Trending at Lumira Ventures

Lumira announces investment in enGene Inc.

admin Portfolio News, enGene

TORONTO, ONTARIO — enGene Inc., a pre-clinical stage biopharmaceutical company developing a platform technology for the robust delivery of nucleotides (DNA or RNA) to the gut, announced today that it has completed an initial closing of a $13.25 million financing …